MRI-guided ablation improves outcomes for younger AFib patients, study shows

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 71%

Technology Technology Headlines News

Technology Technology Latest News,Technology Technology Headlines

Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.

Tulane University researchers presented the findings at the European Society of Cardiology Congress 2023 in Amsterdam this week.

This shows that the younger population with AFib should be treated very quickly and not wait to get ablation treatment. The earlier we treat an arrhythmia in younger populations, the better they do. In general, people tend to wait until they get older to seek treatment. Our finding is that there are more issues when they are starting therapy then and the outcomes are not as good."

Half of the patients received standard care -; pulmonary vein isolation treatment where doctors ablate areas in the left upper chamber of the heart where the four lung veins meet.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in TECHNOLOGY

Technology Technology Latest News, Technology Technology Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AI analysis finds younger AFib patients benefit from MRI-guided ablation treatmentsYounger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.
Source: medical_xpress - 🏆 101. / 51 Read more »